Drug Proarrhythmic Evaluation in a High Throughput Cardiac New Approach Methodology
Verena Charwat, Adrian Ramirez, Karoline Horgmo Jæger, Brennan Kandalaft, Henrik Nicolay Topnes Finsberg, Brian A. Siemons, Aslak Tveito, Kevin E. Healy, Samuel Wall
This paper develops a high-throughput cardiac NAM using hiPSC-derived cardiomyocytes to evaluate drug proarrhythmic potential, showing accurate detection of arrhythmic risk and insights into ion channel effects.
bioRxiv · May 13, 2026 · PreprintPharmacology & Toxicology